Dulaglutide (Trulicity) studies: 418 papers with results
Page 7 of 9
- Lactobacillus reuteri JCM 1112 ameliorates chronic acrylamide-induced glucose metabolism disorder via the bile acid-TGR5-GLP-1 axis and modulates intestinal oxidative stress in mice.
Yue Z · Food & function · 2024
Animal study (in vivo) · mouse · 2 results
- Dulaglutide accelerates diabetic wound healing by suppressing Nrf2-dependent ferroptosis in diabetic mice.
Xi L · Peptides · 2025
Animal study (in vivo) · mouse · 20 results
- An Investigative Study of Pancreatic Exocrine Biomarkers, Histology, and Histomorphometry in Male Zucker Diabetic Fatty (ZDF) Rats Given Dulaglutide by Subcutaneous Injection Twice Weekly for 13 Weeks.
Usborne A · Toxicologic pathology · 2015
Animal study (in vivo) · rat · 9 results
- Dulaglutide treatment reverses depression-like behavior and hippocampal metabolomic homeostasis in mice exposed to chronic mild stress.
Jin M · Brain and behavior · 2024
Animal study (in vivo) · mouse · 4 results
- Activation of glucagon-like peptide-1 receptors and skilled reach foraging.
Vestlund J · Addiction biology · 2021
Animal study (in vivo) · rat · 5 results
- SGLT-2 Inhibitors' and GLP-1 Receptor Agonists' Influence on Neuronal and Glial Damage in Experimental Stroke.
Murasheva A · Biomedicines · 2024
Animal study (in vivo) · rat · 12 results
- Reno-protective effects of GLP-1 receptor agonist and anti-platelets in experimentally induced diabetic kidney disease in male albino rats.
El Amin Ali AM · Iranian journal of basic medical sciences · 2022
Animal study (in vivo) · rat · 7 results
- A glycosylated Fc-fused glucagon-like peptide-1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutide.
An IB · Diabetes, obesity & metabolism · 2020
Animal study (in vivo) · 5 results
- Effects of Dulaglutide in Doxorubicin Induced Renal Toxicity in Rats.
Hama Said HJ · Biologics : targets & therapy · 2025
Animal study (in vivo) · rat · 10 results
- Dulaglutide reduces oxidative DNA damage and hypermethylation in the somatic cells of mice fed a high-energy diet by restoring redox balance, inflammatory responses, and DNA repair gene expressions.
Attia SM · Journal of biochemical and molecular toxicology · 2024
Animal study (in vivo) · mouse · 9 results
- Impact of degradation in subcutaneous tissue and lymphatic fluid on absorption of Fc-fusion proteins following subcutaneous administration.
Yokoyama M · Drug metabolism and pharmacokinetics · 2025
Animal study (in vivo) · rat · 3 results
- Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus-Induced Nephrotoxicity Through Targeting the miR-22/HMGB-1/TLR4/MyD88/NF-κB Trajectory.
Abdelhady R · Archiv der Pharmazie · 2025
Animal study (in vivo) · rat · 10 results
- DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.
Wang W · Journal of endocrinological investigation · 2020
Animal study (in vivo) · mouse · 4 results
- Enhancing GLP-1 expression via IVT mRNA and fusion protein technology for diabetes therapy.
Wu X · Journal of pharmaceutical sciences · 2025
Animal study (in vivo) · mouse · 1 result
- Dulaglutide rescues the elevated testicular dysfunction in a mouse model of high-fat diet-induced obesity.
Attia SM · Mutation research. Genetic toxicology and environmental mutagenesis · 2024
Animal study (in vivo) · mouse · 2 results
- Differential Protective Actions of Dulaglutide and Dexamethasone in Methotrexate Induced Pulmonary Fibrosis: Relationship with AMPK and Beclin-1 Levels.
Maher OW · Biomedicines · 2026
Animal study (in vivo) · rat · 1 result
- Small intestine-permeable cyclic peptide-mediated enhancement of Fc-fusion protein absorption in mice.
Chikamatsu S · Journal of pharmaceutical sciences · 2026
Animal study (in vivo) · mouse · 8 results
- Comparative Analysis of the Anti-Inflammatory Effects of Liraglutide and Dulaglutide.
Hou Y · International heart journal · 2024
In vitro (cells) · 8 results
- Impact of GLP-1 receptor agonists on stroke, subarachnoid hemorrhage, and intracerebral hemorrhage: a propensity-matched multi-institutional cohort study.
Costa M · Journal of neurosurgery · 2026
Not a test of Dulaglutide (Trulicity) alone · 80 results
- Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients With Type 2 Diabetes and Diabetic Retinopathy.
Shah J · American journal of ophthalmology · 2026
Not a test of Dulaglutide (Trulicity) alone · 48 results
- Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial.
Stewart KD · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
Not a test of Dulaglutide (Trulicity) alone · 24 results
- SUN-LB115 Is the Stepping-Down Approach a Better Option Than Multiple Daily Injections in Patients With Chronic Poorly-Controlled Diabetes on Advanced Insulin Therapy?
Naing S · Journal of the Endocrine Society · 2020
Not a test of Dulaglutide (Trulicity) alone · 12 results
- Comparative evaluation of dulaglutide alone vs. dulaglutide combined with probiotics on cardiovascular risk factors in T2DM.
Tian J · Hormones (Athens, Greece) · 2025
Not a test of Dulaglutide (Trulicity) alone · 11 results
- Comparison of IBD-related outcomes in patients with obesity treated with GLP-1 receptor agonists versus bariatric surgery.
Nanah MH · Crohn's & colitis 360 · 2026
Not a test of Dulaglutide (Trulicity) alone · 44 results
- Baseline factors associated with glycaemic response to treatment with once-weekly dulaglutide in patients with type 2 diabetes.
Wysham C · Diabetes, obesity & metabolism · 2016
Not a test of Dulaglutide (Trulicity) alone · 10 results
- Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis.
Nieto LM · The American journal of gastroenterology · 2026
Not a test of Dulaglutide (Trulicity) alone · 36 results
- Interest in Treatment with GLP-1 Receptor Agonists for the Management of Insufficient Weight Loss or Weight Regain After Bariatric Surgery.
Abdallah H · Obesity surgery · 2025
Not a test of Dulaglutide (Trulicity) alone · 18 results
- Association between eating behavior patterns and the therapeutic efficacy of GLP-1 receptor agonists in individuals with type 2 diabetes: a multicenter prospective observational study.
Koide Y · Frontiers in clinical diabetes and healthcare · 2025
Not a test of Dulaglutide (Trulicity) alone · 27 results
- Influence of GLP-1 Receptor Agonists on Surgical and Nonsurgical Treatment of Ankle Osteoarthritis.
Le Y · Foot & ankle specialist · 2026
Not a test of Dulaglutide (Trulicity) alone · 27 results
- Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors.
Ma J · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Not a test of Dulaglutide (Trulicity) alone · 8 results
- Is Weight Loss the Main Driver for A1C Improvement by Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists? A 2.5-Year Analysis in Real-World Clinical Practice.
Al-Badri M · Journal of diabetes · 2025
Not a test of Dulaglutide (Trulicity) alone · 16 results
- Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study.
Al Refaie A · Endocrine · 2025
Not a test of Dulaglutide (Trulicity) alone · 14 results
- Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats.
Aranäs C · British journal of pharmacology · 2025
Not a test of Dulaglutide (Trulicity) alone · 7 results
- The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.
Viljoen A · The European journal of health economics : HEPAC : health economics in prevention and care · 2023
Not a test of Dulaglutide (Trulicity) alone · 14 results
- Long- and Short-Term Cost-Effectiveness of Once-Weekly Semaglutide versus Dulaglutide for the Treatment of Type 2 Diabetes in China: A Hypothetical Modeling Exercise.
Hu Y · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
Not a test of Dulaglutide (Trulicity) alone · 14 results
- Clinical Outcomes of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist (GLP-1/GIP RA) Exposures Presenting to the Emergency Department.
Gartner HT · The Annals of pharmacotherapy · 2025
Not a test of Dulaglutide (Trulicity) alone · 14 results
- Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists.
Kerr KW · Childhood obesity (Print) · 2026
Not a test of Dulaglutide (Trulicity) alone · 21 results
- Characterization of Interchanging Incretin Analogs in Clinical Practice: A Descriptive Report.
Hvisdas CM · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Not a test of Dulaglutide (Trulicity) alone · 14 results
- Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial.
Blonde L · Diabetes care · 2019
Not a test of Dulaglutide (Trulicity) alone · 6 results
- The cost-effectiveness of dulaglutide versus insulin glargine for the treatment of type 2 diabetes mellitus in Japan.
Ishii H · Journal of medical economics · 2018
Not a test of Dulaglutide (Trulicity) alone · 6 results
- The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia.
Malkin SJP · Advances in therapy · 2019
Not a test of Dulaglutide (Trulicity) alone · 10 results
- Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.
Ruan Z · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022
Not a test of Dulaglutide (Trulicity) alone · 12 results
- Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia.
Lasalvia P · Value in health regional issues · 2017
Not a test of Dulaglutide (Trulicity) alone · 10 results
- Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis.
Igarashi A · Advances in therapy · 2020
Not a test of Dulaglutide (Trulicity) alone · 12 results
- Pilot study to test the safety, tolerability and feasibility of dulaglutide during a low-energy diet for weight loss and improved glycaemic control.
Shand JAD · BMJ nutrition, prevention & health · 2023
Not a test of Dulaglutide (Trulicity) alone · 6 results
- Impact of GLP-1 Analogue Therapy on Gastrointestinal Outcomes in Patients with Irritable Bowel Syndrome: A Real-World TriNetX Analysis.
Khan SA · Digestive diseases and sciences · 2026
Not a test of Dulaglutide (Trulicity) alone · 24 results
- Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome.
Yovera-Aldana M · JCEM case reports · 2026
Not a test of Dulaglutide (Trulicity) alone · 16 results
- Effect of ketogenic diet plus dulaglutide on glucose and lipid metabolism in diabetes mellitus.
Gao R · Pakistan journal of pharmaceutical sciences · 2025
Not a test of Dulaglutide (Trulicity) alone · 6 results
- Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis.
Ayoub M · Journal of clinical medicine · 2025
Not a test of Dulaglutide (Trulicity) alone · 15 results
- Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States.
Wilkinson L · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2018
Not a test of Dulaglutide (Trulicity) alone · 10 results